Publications by authors named "Jim Marsters"

Claim this Profile
P
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Kathleen N Moore, Michael J Birrer, Jim Marsters, Yulei Wang, YounJeong Choi

Gynecol Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.
Nerissa Mendoza, Sharon Fong, Jim Marsters, Hartmut Koeppen, Ralph Schwall

Cancer Res· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis